How Esun Helped Top-tier Medical Consumables Distributor Upgrade Antimicrobial Hospital Curtains for Finnish Public Hospitals

Client Profile

Client: Top-tier Medical Consumables Distributor in Finland

Channel Type: Leading Nordic Medical Consumable Distributor

Downstream Clients: Public Hospitals, ICU Critical Care Centers, High-end Private Hospitals in Finland and Nordic Countries

Cooperation Scale: Stable monthly purchase of 1 standard container, average monthly procurement value of USD 15,000

Client’s Core Challenges

1.The original supplier’s dry-spray antimicrobial process only achieved 85%-90% coverage, leaving protective dead spots in fiber gaps. It failed to meet the EU ECDC hospital infection prevention standards, increasing the risk of cross-infection by 30%.

2.The silver ion antimicrobial concentration of the original product was lower than 4%, which could not meet the EU compliance requirements for ICU scenarios, making it impossible to enter the high-threshold procurement list of public hospitals.

3. There was no standardized installation and replacement process, resulting in high labor costs and easy secondary contamination during replacement, which further increased infection risks.

Our Implementation Actions

1. Adopted Hygiesun medical-grade wet impregnation process, where the antimicrobial agent penetrated into the interior of each fiber, achieving a coverage rate of 98%-100%. It maintained 99% antimicrobial performance even after 20 hospital-grade high-temperature washes.

2. Optimized the silver ion antimicrobial formula, with the active concentration stably maintained at 5%-10%, far exceeding EU standards. We provided a full set of supporting documents including BPR compliance, MSDS, and RoHS test reports, enabling access to ICU scenarios.

3.Customized a standardized SOP for installation and replacement, transforming experience-based operations into quantifiable standard actions, increasing single-person replacement efficiency by 60%.

Client’s Quantifiable Results

1.The product fully complied with EU medical standards in all items, and successfully passed the bidding access for ICUs in Finnish public hospitals. The cross-infection risk in terminal hospitals was reduced by 30%, and the ICU infection risk was reduced by 75%.

2.The renewal rate of terminal hospital clients increased from 70% to 95%, with 3 new high-end private hospital partnerships added, representing a 25% growth in the number of terminal clients.

3.The annual labor cost per hospital was savedby USD 75,000, and the infection-related treatment expenditure for terminal hospitals was saved by USD 450,000-900,000 per year.